Lung Cancer Trial, Recruiting (NCT06898333)

Lung Cancer Trial, Recruiting NCT06898333 Sponsor: Washington University School of Medicine Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06898333 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are attending a routine screening mammogram
People who are between 50 and 80 years old (inclusive)
People who have smoked at least 20 pack-years, either as a current smoker or having quit within the last 15 years (confirm with trial site for how pack-years are calculated)
People who can speak and understand English
People who are able to understand the study and are willing to give informed consent

Who may not be able to join:

People who have been diagnosed with a serious health condition that is likely to shorten their life expectancy, such as a previous lung cancer diagnosis, coughing up blood, or unexplained weight loss of more than 6.8 kg (15 lb) in the past year
People who are unwilling or unable to pursue treatment if lung cancer were to be found

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Beryne Odeny, M.D., MPH, Ph.D., Washington University School of Medicine

Phone: 314-362-1183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06898333

Sponsor: Washington University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: 314-362-1183

More information: https://clinicaltrials.gov/study/NCT06898333

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are attending a routine screening mammogram
People who are between 50 and 80 years old (inclusive)
People who have smoked at least 20 pack-years, either as a current smoker or having quit within the last 15 years (confirm with trial site for how pack-years are calculated)
People who can speak and understand English
People who are able to understand the study and are willing to give informed consent

Who may not be able to join:

People who have been diagnosed with a serious health condition that is likely to shorten their life expectancy, such as a previous lung cancer diagnosis, coughing up blood, or unexplained weight loss of more than 6.8 kg (15 lb) in the past year
People who are unwilling or unable to pursue treatment if lung cancer were to be found

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

8 May 2025

Est. completion

30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prevalence of LCS-eligible women who opt-in to, and successfully, complete LCS mammography and opt-in to lung cancer screening; Number of women screened for LCS; Number of women screened for LCS; Feasibility of Pink and Pearl project; Acceptability of Pink and Pearl project; Appropriateness of Pink and Pearl project

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov